The Court issued a unanimous ruling in FDA v. Alliance for Hippocratic Medicine
The United States Supreme Court issued a unanimous ruling in Food and Drug Administration v. Alliance for Hippocratic Medicine. Justice Kavanaugh delivered the opinion of the Court and Justice Thomas filed a concurrence.
The Court’s opinion is based on matters of procedure and not on the merits of FDA authority to approve and promote abortion drugs.
“Although a disappointing loss on standing,” Litigation Counsel Carolyn McDonnell said, “three states have intervened in the case in the district court to help address the standing issue, which means litigation will continue and the fight is not over. The pro-life movement will keep defending women, adolescents, and unborn children from these dangerous drugs.”
Chief Legal Officer and General Counsel Steven H. Aden said, “The use of mifepristone to end human life in the womb continues to be illegal in over a dozen states, and the act of mailing these pills into those states continues to be illegal under federal law. We expect that when the lower courts take up this matter again, they will have to reckon with the consequences of a federal regime that permits the use of a drug that remains unlawful under most circumstances.”
AUL will continue to offer legal prescriptions for the strengthening of protections for unborn children from abortion pills through action on the federal and state levels in both executive and legislative branches of government, including through executive enforcement of the Comstock Act and RICO Act.
